Publications by authors named "Daniel C Mathews"

Claim this Profile
A
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.
Erica M Richards, Daniel C Mathews, David A Luckenbaugh, Dawn F Ionescu, Rodrigo Machado-Vieira

Psychopharmacology (Berl)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.
Mark J Niciu, Daniel C Mathews, Allison C Nugent, Dawn F Ionescu, Maura L Furey

Depress Anxiety· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in mood disorders research: developing new and improved therapeutics.
Mark J Niciu, Daniel C Mathews, Dawn F Ionescu, Erica M Richards, Maura L Furey

Rev Psiquiatr Clin· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
Mark J Niciu, David A Luckenbaugh, Dawn F Ionescu, Daniel C Mathews, Erica M Richards

Biol Psychiatry· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.
Mark J Niciu, Dawn F Ionescu, Daniel C Mathews, Erica M Richards, Carlos A Zarate

CNS Spectr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.
Mark J Niciu, Dawn F Ionescu, Daniel C Mathews, Erica M Richards, Carlos A Zarate

CNS Spectr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine.
Mary C Zeng, Mark J Niciu, David A Luckenbaugh, Dawn F Ionescu, Daniel C Mathews

Biol Psychiatry· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human biomarkers of rapid antidepressant effects.
Carlos A Zarate, Daniel C Mathews, Maura L Furey

Biol Psychiatry· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of ketamine and related compounds for depression.
Daniel C Mathews, Carlos A Zarate

J Clin Psychiatry· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurobiology of anxious depression: a review.
Dawn F Ionescu, Mark J Niciu, Daniel C Mathews, Erica M Richards, Carlos A Zarate

Depress Anxiety· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.
Daniel C Mathews, Ioline D Henter, Carlos A Zarate

Drugs· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis